Primary Antibody supplied by Boster Bio
Know who made it. See the evidence. Buy through one marketplace.
CD82, also known as KAI1, is a four-pass tetraspanin membrane glycoprotein that organises membrane protein complexes and influences cell adhesion, migration and signalling. It is widely studied as a metastasis suppressor because reduced CD82 expression has been associated with tumour progression in several cancer contexts.
Boster Bio PB9170 is a rabbit polyclonal antibody raised against an E. coli-derived human CD82 recombinant protein spanning residues A98-Y267. It is intended for research detection of CD82, while assay and formulation details remain in the structured product specifications.
Fully tested in-house by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC | IHC-P | IHC-F | IF/ICC | Flow Cytometry | ELISA | IP |
|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by Boster Bio and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.